Dr. Belinda Townsend is a Research Fellow at RegNet. She earned her PhD in political science at Deakin University and has undergraduate degrees in political science (Honours), anthropology and public health.
Belinda’s PhD thesis examined the history, conflicts and transformations in the evolution of global medicines governance over the last seventy years. Her thesis traced a pattern of forum-shifting by governments, firms, and globally networked non-government organisations in a battle of power and resistance over the norms and rules that shape global medicines governance.
The conceptual frameworks and findings of this research has informed her recent work on trade policy. She has published on the impact of trade agreements on health with a focus on medicines policy and the Regional Comprehensive Economic Partnership Agreement.
Belinda has served as a resource person on trade and health for the Public Health Association of Australia and has presented for a variety of audiences including community organisations, public forums, academic experts and trade negotiators.
She is working with the NHMRC Centre for Research Excellence in the Social Determinants of Health Equity with Professor Sharon Friel and colleagues on a project investigating agenda setting in public policy.
Global health governance; globalisation; the impact of trade agreements on health; intellectual property; medicines governance.
Negotiators from 11 countries have been racing to resurrect the near-dead Trans-Pacific Partnership Agreement before the Asia-Pacific Economic Cooperation (APEC) summit this weekend. Dr Townsend discusses potential changes in the pipeline for rules affecting biologic drugs, an expensive class of medicines often used to treat conditions such as cancer and rheumatoid arthritis.
Many communities globally are facing considerable changes to employment conditions as economies lose their traditional manufacturing base and attempt to transition to an economy based on advanced manufacturing and knowledge based industries.